Herein, we found that silencing FAM83A markedly decreased CSC-like traits and tumorigenicity and significantly enhanced the sensitivity of pancreatic cancer cells to chemotherapeutic drugs. This evidence concerns the gene SACK1A and pancreatic neoplasm.